Plantar FasciitisNCT07864948
Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis
A study testing Kinesio Taping and Extracorporeal Shock Wave Therapy (ESWT) in people with Plantar Fasciitis, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
Trial summary
This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Plantar Fasciitis
- What is being tested?
- Kinesio Taping and Extracorporeal Shock Wave Therapy (ESWT)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 48 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 27 Aug 2026to 1 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age between 18 and 65 years
- Chronic heel pain for at least 3 months
- Localized pain and tenderness on palpation at the medial aspect of the calcaneal tuberosity with the ankle in full dorsiflexion
- Pain intensity of 50 mm or greater on the Visual Analog Scale (VAS) during the first step in the morning
- Ultrasonographic findings typical of plantar fasciitis (proximal plantar fascia thickness greater than 4 mm with alterations in the fibrillar pattern)
- Willingness to participate in the study and provide written informed consent
Who cannot join
- Presence of any skin lesions or integrity disruption in the heel region
- History of inflammatory or rheumatic arthritis
- History of fracture, trauma, or surgery in the heel region
- Presence of systemic infection or malignancy
- Presence of a cardiac pacemaker
- Local injection into the heel region within the last 6 months, or use of topical or oral non-steroidal anti-inflammatory drugs (NSAIDs) within the last 2 weeks
- Unwillingness to participate in the study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Ankara Bilkent City Hospital
Ankara, Çankaya, 06800
Furkan Çakır, M.D, Specialist, +905072212915, dr.furkancakir@gmail.com
About this study
Official title: Clinical and Ultrasonographic Evaluation of the Effects of Kinesiotaping Combined With Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis: A Randomized Controlled Trial
This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis.
A total of 48 patients with chronic plantar fasciitis will be included in this prospective, randomized controlled trial and randomly allocated into two groups: the ESWT group and the ESWT + Kinesio Taping group.
Primary outcome measures include pain severity assessed via the Visual Analog Scale (VAS) for morning and general pain, foot functionality evaluated using the Foot Function Index (FFI), and plantar fascia thickness measured via ultrasonography. Evaluations will be conducted at baseline, immediately post-treatment, and at the 3-month follow-up.
Read the detailed description
This is a prospective, randomized controlled trial designed to evaluate and compare the efficacy of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) in patients with chronic plantar fasciitis.
Eligible participants will be randomly assigned to one of two groups:
ESWT Group: Patients will receive 3 sessions of focused ESWT at 1-week intervals. Each session will deliver 1800 to 2000 focused shock waves at a frequency of 4-6 Hz and an energy flux density of 0.20-0.30 mJ/mm² targeting the point of maximum tenderness on the medial aspect of the calcaneal tuberosity.
ESWT + Kinesio Taping Group: Patients will receive the same ESWT protocol combined with Kinesio Taping. Taping will be applied twice (once a week for 2 weeks) using a standard 5 cm kinesiology tape. Four strips will be applied with 25% tension from the calcaneus toward the metatarsal heads, and an additional I-band with 50% tension will be applied across the transverse arch. Tapes will remain in place for 5 days per application.
Clinical and ultrasonographic evaluations will be performed at baseline, immediately after the treatment course, and at the 3-month follow-up. Parameters will include pain assessment via the Visual Analog Scale (VAS) for morning and general pain, foot functionality via the Foot Function Index (FFI), and morphological measurement of plantar fascia thickness using ultrasonography.
- Conditions
- Plantar Fasciitis
- Being tested
- Kinesio Taping, Extracorporeal Shock Wave Therapy (ESWT)
- Keywords
- Plantar fasciitis, Extracorporeal shock wave therapy, Kinesio taping, Ultrasonography, ESWT
- Medical subject headings
- Fasciitis, Plantar
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Kinesio TapingOther
Kinesiology tape applied twice (once a week for 2 weeks) with mechanical correction and tension
Extracorporeal Shock Wave Therapy (ESWT)Device
Patients will receive 3 sessions of focused ESWT at 1-week intervals (1800 to 2000 impulses per session at 0.20-0.30 mJ/mm²
| Study group | Role | What they receive |
|---|---|---|
| ESWT Group | Active comparator | Patients will receive 3 sessions of focused extracorporeal shock wave therapy (ESWT) at 1-week intervals Receives: Device: Extracorporeal Shock Wave Therapy (ESWT) |
| ESWT + Kinesio Taping Group | Experimental | Patients will receive focused ESWT combined with Kinesio Taping applied twice (once a week for 2 weeks). Receives: Other: Kinesio Taping; Device: Extracorporeal Shock Wave Therapy (ESWT) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Visual Analog Scale (VAS) Score for Pain
Measured: Baseline, immediately post-treatment, and at 3-month follow-up
Change in Foot Function Index (FFI) Score
Measured: Baseline, immediately post-treatment, and at 3-month follow-up
Change in Plantar Fascia Thickness Measured by Ultrasonography
Measured: Baseline, immediately post-treatment, and at 3-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2026
- Study start27 Aug 2026
- Primary completion1 Mar 2027 (estimated)
- Study completion1 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Plantar FasciitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 48 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ankara City Hospital Bilkent
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Furkan Çakır, Ankara City Hospital Bilkent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07864948
- Sponsor's protocol ID
- TABED-1-26-2947
- Status last verified
- Oct 2026
- First submitted
- 2 Oct 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified participant data will be shared upon reasonable request directed to the corresponding author
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Ultrasonographic Evaluation of the Effects of Kinesiotaping Combined With Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07864948
- Acronym / sponsor ID
- TABED-1-26-2947
- Conditions
- Plantar Fasciitis
- Keywords
- Plantar fasciitis, Extracorporeal shock wave therapy, Kinesio taping, Ultrasonography, ESWT
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 48 participants (estimated)
- Lead sponsor
- Ankara City Hospital BilkentUniversity, hospital or other
- Study start
- 27 Aug 2026 (actual)
- Primary completion
- 1 Mar 2027 (estimated)
- Study completion
- 1 Mar 2027 (estimated)
- First posted
- 8 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis.
A total of 48 patients with chronic plantar fasciitis will be included in this prospective, randomized controlled trial and randomly allocated into two groups: the ESWT group and the ESWT + Kinesio Taping group.
Primary outcome measures include pain severity assessed via the Visual Analog Scale (VAS) for morning and general pain, foot functionality evaluated using the Foot Function Index (FFI), and plantar fascia thickness measured via ultrasonography. Evaluations will be conducted at baseline, immediately post-treatment, and at the 3-month follow-up.
Detailed description
This is a prospective, randomized controlled trial designed to evaluate and compare the efficacy of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) in patients with chronic plantar fasciitis.
Eligible participants will be randomly assigned to one of two groups:
ESWT Group: Patients will receive 3 sessions of focused ESWT at 1-week intervals. Each session will deliver 1800 to 2000 focused shock waves at a frequency of 4-6 Hz and an energy flux density of 0.20-0.30 mJ/mm² targeting the point of maximum tenderness on the medial aspect of the calcaneal tuberosity.
ESWT + Kinesio Taping Group: Patients will receive the same ESWT protocol combined with Kinesio Taping. Taping will be applied twice (once a week for 2 weeks) using a standard 5 cm kinesiology tape. Four strips will be applied with 25% tension from the calcaneus toward the metatarsal heads, and an additional I-band with 50% tension will be applied across the transverse arch. Tapes will remain in place for 5 days per application.
Clinical and ultrasonographic evaluations will be performed at baseline, immediately after the treatment course, and at the 3-month follow-up. Parameters will include pain assessment via the Visual Analog Scale (VAS) for morning and general pain, foot functionality via the Foot Function Index (FFI), and morphological measurement of plantar fascia thickness using ultrasonography.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ESWT Group | Active comparator | Device: Extracorporeal Shock Wave Therapy (ESWT)Patients will receive 3 sessions of focused extracorporeal shock wave therapy (ESWT) at 1-week intervals |
| ESWT + Kinesio Taping Group | Experimental | Other: Kinesio Taping, Device: Extracorporeal Shock Wave Therapy (ESWT)Patients will receive focused ESWT combined with Kinesio Taping applied twice (once a week for 2 weeks). |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age between 18 and 65 years
- Chronic heel pain for at least 3 months
- Localized pain and tenderness on palpation at the medial aspect of the calcaneal tuberosity with the ankle in full dorsiflexion
- Pain intensity of 50 mm or greater on the Visual Analog Scale (VAS) during the first step in the morning
- Ultrasonographic findings typical of plantar fasciitis (proximal plantar fascia thickness greater than 4 mm with alterations in the fibrillar pattern)
Key exclusion criteria (7 listed)
- Presence of any skin lesions or integrity disruption in the heel region
- History of inflammatory or rheumatic arthritis
- History of fracture, trauma, or surgery in the heel region
- Presence of systemic infection or malignancy
- Presence of a cardiac pacemaker
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Kinesio TapingKinesiology tape applied twice (once a week for 2 weeks) with mechanical correction and tension | Other | ESWT + Kinesio Taping Group |
| Extracorporeal Shock Wave Therapy (ESWT)Patients will receive 3 sessions of focused ESWT at 1-week intervals (1800 to 2000 impulses per session at 0.20-0.30 mJ/mm² | Device | ESWT + Kinesio Taping Group, ESWT Group |
Primary outcome
Change in Visual Analog Scale (VAS) Score for Pain
Time frame: Baseline, immediately post-treatment, and at 3-month follow-up
Change in Foot Function Index (FFI) Score
Time frame: Baseline, immediately post-treatment, and at 3-month follow-up
Change in Plantar Fascia Thickness Measured by Ultrasonography
Time frame: Baseline, immediately post-treatment, and at 3-month follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
- Individual participant dataSharing planned: Yes. De-identified participant data will be shared upon reasonable request directed to the corresponding author
Related trials for Plantar Fasciitis
RecruitingObservational study
Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis
Plantar Fasciitis, Chronic, Tibial Nerve
Recruiting
Video-Based Versus Physician-Led Exercise Training for Plantar Fasciitis
Plantar Fasciitis of Both Feet, Plantar Fascitis
Recruiting
Comparison of Transverse Friction Massage and Instrument- Assisted Soft-Tissue Mobilization in Plantar Fasciitis
Plantar Fasciitis
Active, not recruiting
Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis
Planter Fasciitis
Recruiting
Effects of Deep Transverse Friction Massage and Instrument Assisted Soft Tissue Mobilization in Plantar Fasciitis.
Plantar Fascitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesio Taping and Extracorporeal Shock Wave Therapy (ESWT) in people with Plantar Fasciitis, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Furkan Çakır, M.D, Specialist (+905072212915, dr.furkancakir@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Visual Analog Scale (VAS) Score for Pain (time frame: Baseline, immediately post-treatment, and at 3-month follow-up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.